Prados-Ojeda, Juan LLuque-Luque, RogelioGordillo-Urbano, Rafael MGuler, IpekLópez-Medina, ClementinaCollantes-Estévez, EduardoEscudero-Contreras, Alejandro2025-01-072025-01-072021-08-042077-0383https://hdl.handle.net/10668/28311Inflammatory and autoimmune processes have been associated with the onset of depressive and psychotic symptoms. Rheumatoid arthritis (RA) and spondyloarthritis (SpA) are rheumatic diseases with an inflammatory etiology. A high prevalence of depressive and anxiety-related comorbidity has been reported for both diseases, with no evidence of a greater prevalence of psychosis. The objective of the present study was to evaluate for the first time subclinical psychotic symptoms in patients with RA and SpA. This is a cross-sectional, single-center study including RA and SpA patients, as well as healthy controls. Abnormal psychotic experiences (positive, negative, and depressive symptoms) were evaluated using the Community Assessment of Psychic Experiences (CAPE-42). Functional capacity was evaluated using the Short-Form Health Survey SF-12. We compared the CAPE and SF-12 scores between the three groups. We recruited 385 individuals: 218 with RA, 100 with SpA, and 67 healthy controls. According to the CAPE scale, the frequency of subclinical psychotic symptoms was greater in patients than in healthy controls (RA, 1.90 vs. 1.63, penAttribution 4.0 Internationalhttp://creativecommons.org/licenses/by/4.0/anxietyautoimmunitydepressioninflammationpsychotic symptomsrheumatoid arthritisspondyloarthritisresearch article34441756open access10.3390/jcm10163461PMC8396915https://www.mdpi.com/2077-0383/10/16/3461/pdf?version=1628142695https://pmc.ncbi.nlm.nih.gov/articles/PMC8396915/pdf